Literature DB >> 1127997

Mesenteric angiofollicular lymph node hyperplasia (lymphoid hamartoma) with nephroitc syndrome.

S R Humpherys, K E Holley, L H Smith, D C McIlrath.   

Abstract

In an 18-year-old woman who presented with the nephrotic syndrome and an abdominal mass, removal of a benign mesenteric lymphoid tumor was associated with remission of the nephrotic syndrome without further recurrence (30 month follow-up). Biopsies of both kidneys showed a minimal-change glomerular lesion. Clinical and pathologic characteristics of angiofollicular lymph node hyperplasia and its possible relationship to the nephrotic syndrome are discussed.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1127997

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  7 in total

1.  Giant lymph node hyperplasia (Castleman's disease): a clinical study of eight patients.

Authors:  Y Baruch; Y Ben-Arie; H Kerner; M Lorber; L A Best; R Gershoni-Baruch
Journal:  Postgrad Med J       Date:  1991-04       Impact factor: 2.401

Review 2.  Renal complications of Castleman's disease: report of two cases and analysis of 75 cases.

Authors:  Xiang-Gui Yuan; Wen Hu; Fei-Fei Chen; Bin-Feng Huang; Xiao-Ying Zhao
Journal:  Clin Exp Nephrol       Date:  2011-08-06       Impact factor: 2.801

3.  Laparoscopy-assisted resection for Mesenteric Castleman's disease: Report of a case.

Authors:  Mitsuhiko Ohta; Manabu Yamamoto; Tetsuzo Tagawa; Eiji Tsujita; Ayumi Matsuyama; Jin Okazaki; Tohru Utsunomiya; Shinichi Tsutsui; Megumu Fujihara; Teruyoshi Ishida
Journal:  Surg Today       Date:  2011-09-16       Impact factor: 2.549

Review 4.  Castleman's disease of the abdomen and pelvis: report of three cases and a review of the literature.

Authors:  H Kiguchi; T Ishii; Y Ishikawa; S Masuda; N Asuwa; K Yamafuji; T Takahashi
Journal:  J Gastroenterol       Date:  1995-10       Impact factor: 7.527

5.  Castleman's disease with coagulation defect. A case report.

Authors:  S C Rizzo; C L Balduini; G Gamba; R Invernizzi; G Grignani; C Mauri
Journal:  Blut       Date:  1984-08

Review 6.  Neoadjuvant radiotherapy of primary irresectable unicentric Castleman's disease: a case report and review of the literature.

Authors:  Iris A C de Vries; Marjolein M S van Acht; Thomas B J Demeyere; Marnix L M Lybeert; Jean-Paul de Zoete; Grard A P Nieuwenhuijzen
Journal:  Radiat Oncol       Date:  2010-02-02       Impact factor: 3.481

7.  Increased interleukin-6 (IL-6) production in a young child with clinical and pathologic features of multicentric Castleman's disease.

Authors:  M C Kinney; D S Hummell; P M Villiger; A Hourigan; L Rollins-Smith; A D Glick; A R Lawton
Journal:  J Clin Immunol       Date:  1994-11       Impact factor: 8.317

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.